Gsa Capital Partners LLP Volitionrx LTD Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$3.01 - $3.78 $83,422 - $104,762
-27,715 Closed
0 $0
Q1 2021

May 10, 2021
SELL
$3.33 - $6.5 $293,772 - $573,430
-88,220 Reduced 76.09%
27,715 $105,000
Q4 2020

Feb 03, 2021
BUY
$2.88 - $4.33 $7,729 - $11,621
2,684 Added 2.37%
115,935 $451,000
Q3 2020

Nov 06, 2020
BUY
$2.94 - $4.05 $332,957 - $458,666
113,251 New
113,251 $364,000

Others Institutions Holding VNRX

# of Institutions
26
Shares Held
17.8M
Call Options Held
41K
Put Options Held
100
View Full List

About VOLITIONRX LTD

VNRX Quotes by TradingView
  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $39M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email